These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36855335)

  • 1. Anti-HER2 scFv-nCytc-Modified Lipid-Encapsulated Oxygen Nanobubbles Prepared with Bulk Nanobubble Water for Inducing Apoptosis and Improving Photodynamic Therapy.
    Tian J; Wan S; Tian J; Liu L; Xia J; Hu Y; Yang Z; Zhao H; Wang H; Guo Y; Guo J
    Small; 2023 Jun; 19(23):e2206091. PubMed ID: 36855335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PDL1/HER2-Targeted Lipid-Encapsulated Oxygen Nanobubbles Combined with Photodynamic Therapy for HER2
    Tian J; Wan S; Yang Z; Wang M; Zhou W; Wo G; Fu S; Zheng S; Zhou G; Hu X; Guo Y; Guo J
    Adv Healthc Mater; 2024 Dec; 13(31):e2400030. PubMed ID: 39113347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biogenic nanobubbles for effective oxygen delivery and enhanced photodynamic therapy of cancer.
    Song L; Wang G; Hou X; Kala S; Qiu Z; Wong KF; Cao F; Sun L
    Acta Biomater; 2020 May; 108():313-325. PubMed ID: 32268236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid-Polymer Bilaminar Oxygen Nanobubbles for Enhanced Photodynamic Therapy of Cancer.
    Song R; Hu D; Chung HY; Sheng Z; Yao S
    ACS Appl Mater Interfaces; 2018 Oct; 10(43):36805-36813. PubMed ID: 30300545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted co-delivery of a photosensitizer and an antisense oligonucleotide based on an activatable hyaluronic acid nanosystem with endogenous oxygen generation for enhanced photodynamic therapy of hypoxic tumors.
    Wu Y; Ding L; Zheng C; Li H; Wu M; Sun Y; Liu X; Zhang X; Zeng Y
    Acta Biomater; 2022 Nov; 153():419-430. PubMed ID: 36115655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synchronous delivery of oxygen and photosensitizer for alleviation of hypoxia tumor microenvironment and dramatically enhanced photodynamic therapy.
    Guo X; Qu J; Zhu C; Li W; Luo L; Yang J; Yin X; Li Q; Du Y; Chen D; Qiu Y; Lou Y; You J
    Drug Deliv; 2018 Nov; 25(1):585-599. PubMed ID: 29461122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An intelligent dual stimuli-responsive photosensitizer delivery system with O
    Zhao H; Li L; Zheng C; Hao Y; Niu M; Hu Y; Chang J; Zhang Z; Wang L
    Colloids Surf B Biointerfaces; 2018 Jul; 167():299-309. PubMed ID: 29679806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual-action nanoplatform with a synergetic strategy to promote oxygen accumulation for enhanced photodynamic therapy against hypoxic tumors.
    Ren C; Xu X; Yan D; Gu M; Zhang J; Zhang H; Han C; Kong L
    Acta Biomater; 2022 Jul; 146():465-477. PubMed ID: 35526738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Hypoxia Nanoplatforms for Enhanced Photosensitizer Uptake and Photodynamic Therapy Effects in Cancer Cells.
    Nkune NW; Abrahamse H
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune/Hypoxic Tumor Microenvironment Regulation-Enhanced Photodynamic Treatment Realized by pH-Responsive Phase Transition-Targeting Nanobubbles.
    Zhao M; Yang X; Fu H; Chen C; Zhang Y; Wu Z; Duan Y; Sun Y
    ACS Appl Mater Interfaces; 2021 Jul; 13(28):32763-32779. PubMed ID: 34235912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monocytic delivery of therapeutic oxygen bubbles for dual-modality treatment of tumor hypoxia.
    Huang WC; Shen MY; Chen HH; Lin SC; Chiang WH; Wu PH; Chang CW; Chiang CS; Chiu HC
    J Control Release; 2015 Dec; 220(Pt B):738-50. PubMed ID: 26374945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-delivery of gefitinib and hematoporphyrin by aptamer-modified fluorinated dendrimer for hypoxia alleviation and enhanced synergistic chemo-photodynamic therapy of NSCLC.
    Zhu F; Xu L; Li X; Li Z; Wang J; Chen H; Li X; Gao Y
    Eur J Pharm Sci; 2021 Dec; 167():106004. PubMed ID: 34520834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supramolecular micelles as multifunctional theranostic agents for synergistic photodynamic therapy and hypoxia-activated chemotherapy.
    Huang X; Chen T; Mu N; Lam HW; Sun C; Yue L; Cheng Q; Gao C; Yuan Z; Wang R
    Acta Biomater; 2021 Sep; 131():483-492. PubMed ID: 34265471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxygen nanobubbles revert hypoxia by methylation programming.
    Bhandari PN; Cui Y; Elzey BD; Goergen CJ; Long CM; Irudayaraj J
    Sci Rep; 2017 Aug; 7(1):9268. PubMed ID: 28839175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Programmable therapeutic nanoscale covalent organic framework for photodynamic therapy and hypoxia-activated cascade chemotherapy.
    He H; Du L; Xue H; Wu J; Shuai X
    Acta Biomater; 2022 Sep; 149():297-306. PubMed ID: 35811069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-HER2 Affibody-Conjugated Photosensitizer for Tumor Targeting Photodynamic Therapy.
    Li S; Jin Y; Su Y; Li W; Xing Y; Wang F; Hong Z
    Mol Pharm; 2020 May; 17(5):1546-1557. PubMed ID: 32267710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An albumin-binding dimeric prodrug nanoparticle with long blood circulation and light-triggered drug release for chemo-photodynamic combination therapy against hypoxia-induced metastasis of lung cancer.
    Luo R; Zhang Z; Han L; Xue Z; Zhang K; Liu F; Feng F; Xue J; Liu W; Qu W
    Biomater Sci; 2021 May; 9(10):3718-3736. PubMed ID: 34008617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterial Toxin-Responsive Biomimetic Nanobubbles for Precision Photodynamic Therapy against Bacterial Infections.
    Zhuge D; Li L; Wang H; Yang X; Tian D; Yin Q; Chen H; Weng C; Wen B; Lin Y; Huh JY; Zhang X; Chen M; Xie C; Zhao Y; Chen Y
    Adv Healthc Mater; 2022 Sep; 11(18):e2200698. PubMed ID: 35836329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Grade-targeted nanoparticles for improved hypoxic tumor microenvironment and enhanced photodynamic cancer therapy.
    Tao YK; Hou XY; Gao H; Zhang X; Zuo FM; Wang Y; Li XX; Jiang G
    Nanomedicine (Lond); 2021 Feb; 16(3):221-235. PubMed ID: 33533660
    [No Abstract]   [Full Text] [Related]  

  • 20. Oxygen-producing catalase-based prodrug nanoparticles overcoming resistance in hypoxia-mediated chemo-photodynamic therapy.
    Cheng X; He L; Xu J; Fang Q; Yang L; Xue Y; Wang X; Tang R
    Acta Biomater; 2020 Aug; 112():234-249. PubMed ID: 32502633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.